Liz Szabo
From this contributor
How anti-vaccine activists are using COVID-19 to boost their movement
While most of the world hungers for a vaccine to put an end to the death and economic destruction wrought by COVID-19, some anti-vaccine groups are joining anti-lockdown protesters to challenge restrictions aimed at protecting public health.
How anti-vaccine activists are using COVID-19 to boost their movement
Landmark mental health bill sails through U.S. Senate
The 21st Century Cures Act, having passed the U.S. Senate, now goes to President Barack Obama, who has promised to sign it.
Landmark mental health bill sails through U.S. Senate
Massive mental health bill faces vote in U.S. Congress
If passed, the $6.3 billion 21st Century Cures Act would make mental health a national priority.
Massive mental health bill faces vote in U.S. Congress
Explore more from The Transmitter
Additional data suggest changes in diagnostics underlie increases in autism diagnoses, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 14 September.
Additional data suggest changes in diagnostics underlie increases in autism diagnoses, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 14 September.
Building brain-computer interfaces at a neurotech company
At Blackrock Neurotech, Spencer Kellis develops implantable devices that help people with brain and spinal cord conditions communicate, move and more.
Building brain-computer interfaces at a neurotech company
At Blackrock Neurotech, Spencer Kellis develops implantable devices that help people with brain and spinal cord conditions communicate, move and more.
‘High risk, high reward’: How early-career neuroscientists view their future
The Transmitter and Neuromatch surveyed more than 300 early-career neuroscientists to better understand their unique challenges, career aspirations and support needs.
‘High risk, high reward’: How early-career neuroscientists view their future
The Transmitter and Neuromatch surveyed more than 300 early-career neuroscientists to better understand their unique challenges, career aspirations and support needs.